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 Mexican Chiapas cheese shows high proteolytic activity by native bacteria.  
 Chiapas cheese showed up to 0.78 g/kg of antihypertensive GABA content. 
 Chiapas cheese elicit angiotensin-I converting enzyme inhibition. 
 Fermented milk of selected isolates induced ACE inhibitory & antioxidant activities. 
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Abstract
1
 9 
Chiapas cream cheese (CCH) manufacturing process involves a long acid-enzymatic coagulation period 10 
of full-fat cow raw milk to achieve an acid and crumbly cheese. These sensorial aspects are related to 11 
lactic acid bacteria activity during ripening.  Our main objective was to test the hypothesis that CCH 12 
contained highly proteolytic strains able to release bioactive compounds upon milk-protein hydrolysis. 13 
First, the proteolysis of CCH was evaluated considering the peptide and amino acid profiles of cheese 14 
samples collected from Veracruz (AVCH) and Tabasco (HTCH). The angiotensin-converting-enzyme 15 
(ACE) inhibitory activity in cheese water-soluble fractions was evaluated. Thereafter, strains from both 16 
CCH samples were isolated and selected based on their proteolytic capability, genetic fingerprint 17 
differentiation and growth conditions. Finally, a range of activities in vitro were tested in milk fractions 18 
                                                          
1
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fermented with selected strains. CCH showed ACE inhibitory activity: IC50=1.75-2.75 mg/mL. 19 
Interestingly, AVCH contains 0.78 g/kg of the antihypertensive γ-aminobutyric acid. Three highly 20 
proteolytic strains showed ACE and high antioxidant activities upon milk fermentation. In conclusion, 21 
CCH contain proteolytic strains able to release bioactive compounds from milk proteins and potentially 22 
useful to produce functional ingredients and foods. 23 
Keywords: 24 
Chiapas cheese; proteolysis; GABA; ACE-inhibitory activity; antioxidant  25 
1. Introduction  26 
Chiapas cream cheese (CCH) is a semi-ripened traditional cheese manufactured in the tropical south of 27 
Mexico. It is characterised by its acidic taste and creamy sensory properties (i.e. mouth feel). These 28 
characteristics are conferred during the process that involves 3-5 h of whole raw milk maturation 29 
followed by 2- 8 h of coagulation and acidification by endogenous lactic acid bacteria (LAB) at tropical 30 
conditions (>25°C) (González-Córdova et al., 2016). CCH was reported a humidity of 48%, a pH about 31 
4.0, and 5% of NaCl (Morales, Morales, Hernández, & Hernández-Sánchez, 2011). LAB are able to 32 
release bioactive compounds from milk proteins by proteolysis during cheese ripening.  For instance, 33 
Lactobacillus (Lb.) helveticus DSM13137, a proteolytic cheese starter,  releases the antihypertensive 34 
peptides  Ile-Pro-Pro and Val-Pro-Pro during milk fermentation (Seppo, Jauhiainen, Poussa, & Korpela, 35 
2003). The ACE inhibitory activity (ACEi) has been attributed as one of the main antihypertensive 36 
mechanisms of bioactive peptides. ACEi was reported in ripened  Red Cheddar and Camembert with an 37 
IC50, the amount of protein to inhibit the ACE activity by 50%, as low as 0.16 mg/mL, whereas non 38 
activity was detected in cottage, an unripen cheese (Okamoto et al., 1995). Furthermore, Gupta, Mann, 39 
Kumar & Sangwan (2013) showed a clear relationship between degree of hydrolysis (DH) and an 40 
increase of ACEi in cheese water-soluble fraction (WSF) when adding  adjunct cultures at different 41 
stages of ripening Cheddar cheeses.  Also, a positive correlation between ripening and the radical 42 
scavenging capability of Cheddar WSF was found when adding Lb. casei ssp casei 300 as adjunct 43 
culture (Gupta, Mann, Kumar, & Sangwan, 2009).  Indeed,  it was reported that CCH possess higher 44 
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antioxidant activity (AO) than other Mexican cheeses when assessed by the oxygen radical absorbance 45 
capacity (ORAC) method, suggesting that greater proteolytic activity in CCH compared to other cheese 46 
released more antioxidant compounds (Santiago-López et al., 2018). LAB strains with potential 47 
proteolytic activity have been reported in CCH (Morales et al., 2011). Also, CCH halotolerant strains 48 
Lb. plantarum, Lb. pentosus, and Lb. acidipiscis have shown probiotic characteristics such as 49 
antimicrobial activity and adhesion to mucin (Melgar-Lalanne, Rivera-Espinoza, Reyes Méndez, & 50 
Hernández-Sánchez, 2013). Nonetheless, no studies have been published on the proteolytic activity of 51 
the microbiota contained in CCH and their ability to releasing bioactive compounds. Thus, the main 52 
objective of this study was to investigate a range of potential functionalities, i.e. antihypertensive, and 53 
/or antioxidant activities, associated to the proteolytic activity of the microbiota present in CCH. Our 54 
first approach was to study the proteolysis occurred in CCH from two different regions considering the 55 
peptide and amino acid profile. Also, ACEi of cheese WSF was assessed. Subsequently, isolated strains 56 
from CCH samples were selected based on their proteolytic activity, ability to produce diacetyl and no 57 
catalase production and genetical fingerprint differentiation by using RAPD-PCR technique. ACEi and 58 
antioxidant activities were investigated in whey fermented with selected strains, which could potentially 59 
be used in the formulation and production of functional foods. 60 
2. Material and methods 61 
2.1 Reagents and cheese sample preparation and characterisation 62 
Unless otherwise stated chemicals and reagents were obtained from Sigma-Aldrich, UK. Cheese 63 
samples labelled as “Queso Chiapas doble crema” were purchased from Mexican local markets at 64 
Acayucan Veracruz (AVCH) and Huimanguillo Tabasco (HTCH) from recent manufacture (1 week,  65 
according to the date of production labelled on the package) and stored at 5 °C. Samples for microbial 66 
isolation and bioactivity assessment were diluted in phosphate buffered saline (PBS); (0.01 M phosphate 67 
buffered saline (NaCl 0.138 M; KCl - 0.0027 M); pH 7.4, at 25 °C, 10% w/v). For amino acid analysis, 68 
samples were diluted in 0.1 N HCl (10%, w/v) and vortexed until complete dissolution. Diluted samples 69 
to be assessed for bioactivity were stored at -20 °C. For pH determination 1 g of cheese was 70 
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homogenised by using a vortex in 10 mL of distilled water and measure in a pH meter Hannah 71 
Instruments pH 211.  72 
2.2 Determination of total protein, degree of hydrolysis and peptide profile 73 
The total amount of proteins (TP) was determined using bicinchoninic acid as described by Gonzalez-74 
Gonzalez, Tuohy & Jauregi (2011). The degree of hydrolysis (DH%) was determined using the method 75 
of o-phthaldialdehyde (OPA) described by Nielsen, Petersen & Dambmann (2001) and modified by 76 
Gonzalez-Gonzalez et al. (2011). The peptide profile was determined by reversed-phase high 77 
performance liquid chromatography (RP-HPLC) using a gradient as described by Gonzalez-Gonzalez, 78 
Gibson & Jauregi (2013).  79 
2.3 Amino acid profile of cheese samples 80 
The free amino acid (FAA) profiles of cheese samples, including γ-aminobutyric acid (GABA), were 81 
examined using a derivatisation assay kit EZ-Faast (Phenomenex USA), and running on a GC- Agilent 82 
6890 GC-5975-MS system (Agilent, USA) in electron impact mode. The method used is based on 83 
Elmore, Koutsidis, Dodson, Mottram, & Wedzicha (2005). The results were compared to those found in 84 
raw milk.  85 
2.4 Isolation of bacteria 86 
Bacterial isolation was carried out under both aerobic and anaerobic conditions at 37 °C by spread-87 
plating ten-fold serial dilutions (prepared in half-strength peptone water) on appropriate agar plates; de 88 
Man Rogosa Sharpe (MRS) agar for aerobic cultivation and both MRS agar and Columbia blood agar 89 
for anaerobic cultivation (Oxoid Ltd., UK). One of each different colony morphotype from each plate 90 
was subcultured, together with randomly selected colonies to obtain an equal number of isolates from 91 
each plate (cheese, agar type and cultivation conditions). Colonies were subcultured on the same agar 92 
type and incubated for 48 h appropriately (aerobic/anaerobic) to obtain pure cultures. Purified isolates 93 
were then stored on cryogenic Microbank
TM
 beads (ProLab Diagnostics, UK) at -80 ºC.  94 
2.5 Genetic fingerprinting of bacterial isolates 95 
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DNA was extracted from each isolate using the phenol/chloroform method and randomly amplified 96 
polymorphic DNA-PCR (RAPD-PCR) employed to estimate the genetic variations of the isolates. The 97 
reaction mixture (25 μL) comprised 5 μL of 5x GoTaq Flexi buffer (Promega, UK), 2.5 μL of dNTPs 98 
(0.4 mmol/L of each of dATP, dCTP, dGTP, dTTP; Promega), 1.5 μL of MgCl2 (25 mmol/L; Promega), 99 
1 μL of primer OPA-09 (5’-GGGTAACGCC-3’; 20 pmol/mL; Sigma Genosys, UK), 1 μL of GoTaq 100 
DNA polymerase (1.5 U/ μL; Promega), 1 μL of template DNA (5 ng/μL) and 13 μL of sterile water. 101 
PCR was performed using Prime thermal cycler (with heated lid, 100 ºC; Techne) programmed for 40 102 
cycles of denaturation (30 sec at 94 ºC), annealing (60 sec at 38 ºC) and extension (2 min at 72 ºC), with 103 
a final 10 min extension step (72 ºC). The reaction products were separated via agarose gel 104 
electrophoresis (1.5% in 1x TAE buffer [Fisher, UK] containing ethidium bromide [0.5 ng/mL]), using 105 
1 Kb DNA ladder (Promega) as a molecular size indicator. DNA fragment patterns were visualized 106 
under UV light (Genesnap, Syngene) and analysed by Gel Compar II software.  107 
2.6 Fermentation of milk by isolated strains, diacetyl and catalase test 108 
Bacterial strains were reactivated on appropriate agar plates (aerobically/anaerobically), checked for 109 
purity (single colony type) and overnight brain heart infusion (BHI) broth cultures prepared (aerobically 110 
or anaerobically, as per original isolation). Milk fermentations were carried out in Hungate tubes with 111 
15 mL of 10% (w/v) reconstituted skim milk (RSM) using 1% inoculum of fresh overnight broth culture 112 
for each isolate (affording initial number of 10
6
-10
7
 cells/mL). A negative control, using uninoculated 113 
BHI (1%) was also included. The fermentations were incubated at 30 ºC with continuous agitation for 114 
24 h. Samples of 2 mL were then taken and heated to 72 ºC for 1 min to stop the enzymatic proteolysis 115 
and then centrifuged at 12,000 g for 10 min. The supernatant was filtered and stored at –20 ºC until 116 
further analysis.  117 
The catalase test was performed by mixing a colony into a drop of 3% hydrogen peroxide. Diacetyl 118 
production was determined to the supernatant fermented whey fraction according to King (1948). A 119 
purple ring at the top of the solution indicated the presence of diacetyl. 120 
2.7 Activity in vitro assays 121 
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Assays for ACEi was performed in cheese samples. Furthermore, the ACEi and antioxidant activities 122 
were performed on fermented milk soluble fractions (FMSF) of selected strains according to criteria 123 
discussed below in section 3.3.   124 
ACE inhibitory activity 125 
The ACEi of cheese samples was determined using N-[3-(2-furyl)acryloyl]-Phe-Gly-Gly (FAPGG) 126 
according to the method described by Henda et al. (2013) with some modifications. Briefly, in a 127 
microplate well 10 µL of ACE (250 mU solution with 0.05 M Tris, 0.3 M NaCl in 50% glycerol 128 
solution, with the pH adjusted to 7.5 with 5 M HCl) was mixed with 150 µL of 0.88 mmol/L FAPGG in 129 
0.05 M Tris, 0.3 M NaCl and 10 µL of test sample (diluted cheese or fermented milk fraction). 0.05 M 130 
Tris, 0.3 M NaCl buffer was used as negative control and 5 M HCl was used as positive control 131 
(standard inhibition). The reaction kinetics was followed in a Tecan Microplate Reader – A-5082 132 
Spectra FLUOR plus (Austria) for 30 minutes to obtain the slope inhibitor [FAPGG] vs time (min). The 133 
ACEi% was calculated in relation to the slope generated when no inhibitor was present in the reaction 134 
(slope blank) according to equation 1 (below).  135 
 136 
Equation 1 ACEi% = [1 – (slope inhibitor/slope blank)] × 100  137 
 138 
The IC50, defined as the concentration of protein needed to inhibit the activity of the enzyme by half, 139 
was calculated as the concentration needed to reduce the slope by 50% in relation to the slope blank. 140 
The ACEi% in fermented milk fractions with selected strains, as described above, was determined 141 
according to the HPLC method described by Gonzalez-Gonzalez et al. (2011) using Hip-His-Leu as 142 
substrate.  143 
Antioxidant activity de FRAP 144 
The ferric reducing antioxidant power (FRAP) assay, based on the reduction of Fe(III) to Fe(II) by the 145 
action of antioxidants present, was performed according to Benzie & Strain (1996). Serial dilutions of 146 
ascorbic acid were used as standards.  147 
 148 
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Antioxidant activity by ABTS+• radical 149 
For the trolox equivalent antioxidant capacity (TEAC) assay a solution of 2,2′-azinobis(3-150 
ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS
+•
 ) radical was prepared according to the 151 
method described by Guo & Jauregi (2018). Triplicates of each reaction were read at 734 nm in a 152 
spectrophotometer Amersham Ultrospec 1100 Pro UV/Vis (Uppsala, Sweden). Trolox standards were 153 
used for quantification and data was expressed as µmol trolox equivalent (TE). The antioxidant activity 154 
(AA%) was calculated by using equation 2 (below). 155 
  156 
Equation 2       
         
          
     157 
 158 
Where ABScontrol is the absorbance of ABTS
+•
 in PBS and ABSsample is the reaction absorbance with the sample. 159 
 160 
 161 
2.8 Data analysis and statistics 162 
All data analysis including one-way analysis of variance and Tukey post-hoc test were performed for 163 
comparative analysis among means for each bioactivity using R v.3.4.3. (R-Core-Team, 2017). 164 
3. Results and Discussion 165 
3.1 Proteolysis in Chiapas cheese  166 
The proteolytic activity undergoing in CCH samples is depicted in the peptide profile chromatograms. 167 
Fig. 1 showed intact milk proteins in RSM as control (Fig. 1A), and a significant breakdown in AVCH 168 
(Fig. 1B) and HTCH (Fig. 1C) peptides profiles. Larger peak areas of peptides in AVCH suggests 169 
higher proteolytic activity than in HTCH. This is confirmed by the FAA profiles, which show higher 170 
concentrations of total FAA in AVCH (3.89 g/kg) than in HTCH (0.37 g/kg) (Table 2). These 171 
concentrations are similar to those found in Spanish cheese (0.19 and 69 g/kg) (Diana, Rafecas, Arco, & 172 
Quílez, 2014). Moreover, the essential amino acids (AA) leucine, phenylalanine, lysine and valine were 173 
found in important amounts as FAA in AVCH and much higher than in HTCH.  Additionally, Ornithine 174 
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(Orn), a non-proteinogenic AA found in certain types of ripened and semi-ripened cheeses, was found in 175 
AVCH samples (0.18 g/kg) but not in HTCH samples. These differences on the peptide and FAA 176 
profiles may be explained by the activity of the microbiota of each sample as well as the differences in 177 
the manufacturing process (Santiago-López et al., 2018). Also, other factors such as salt content, pH and 178 
temperature storage may influence the release of FAA (Diana et al., 2014). 179 
 180 
GABA is an important antihypertensive AA produced by LAB by the decarboxylation of glutamate. In 181 
this study, GABA was 0.78 g/kg in AVCH (Table 2), being one of the highest GABA concentrations 182 
reported in cheese made of bovine milk so far; it has been found in Gouda (0.177 g/kg), Cheddar (0.048 183 
g/kg) and blue cheese (0.007 g/kg) (Nomura, Kimoto, Someya, Furukawa, & Suzuki, 1998). Diana et 184 
al., (2014) reported GABA in Spanish cheeses in amounts ranging from 0.01 to 0.31 g/kg in cheese 185 
made of cow’s milk and 0.07 to 0.98 g/kg in cheese made of ewe’s milk.  Nejati et al. (2013) reported a 186 
fermented milk using a selected Lb. plantarum PU11 yielding up to 0.14 g/kg GABA after 120 h of 187 
fermentation. Also, Lacroix, St. Gelais, Champagne, & Vuillemard (2013) identified cheese starters 188 
Lactococcus lactis with high GABA production yielding up to 3.4 g/kg of GABA in Danish Havarti 189 
cheese with added culture, attributing this to an extensive ripening and proteolysis. Also, glutamic acid 190 
was found in raw milk, yet it was not detected in cheese suggesting that it has been converted to GABA 191 
by LAB. Moreover, a reduction in blood pressure in mild-hypertensive patients was achieved following 192 
a 12-weeks intake of fermented milk with 0.010–0.012 g of GABA per day  (Inoue et al., 2003). This 193 
content of GABA would be equivalent to daily consumption of approximately 13 g of AVCH. 194 
 195 
3.2 ACE inhibitory activity in vitro in cheese samples 196 
ACE inhibitory peptides may be released during cheese ripening. Although AVCH showed lower ACE 197 
inhibitory potency (i.e. higher IC50 value), no significant differences were found in ACEi between the 198 
two cheese samples (Table 1). The ACEi has been investigated in the norwegian traditional cheese 199 
Gamalost reporting  IC50 values as low as 0.34 ± 0.07  mg/mL after 10 days of ripening with native 200 
microbiota (Qureshi, Vegarud, Abrahamsen, & Skeie, 2012). In a cheddar cheese enriched with Lb. 201 
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casei subps casei IC50 values were as low as 0.160 ± 0.002 after 3 months of ripening (Ong, Henriksson, 202 
& Shah, 2007). They observed that ACEi potency declines in cheese after a long period of ripening due 203 
to further proteolysis of bioactives peptides into their constituent AAs. This may explain why AVCH 204 
with higher proteolytic activity showed lower ACEi potency than HTCH samples.  205 
3.3 Isolation and selection of highly proteolytic strains 206 
Our research aim was to screen highly proteolytic native bacteria in CCH that were able to release 207 
bioactive compounds.  A total of 89 bacterial strains were isolated (anaerobically and aerobically) but 208 
only 84 isolates were able to be subcultured and characterised. RAPD-PCR was performed to obtain a 209 
simple genetic fingerprint for each isolate and thus identify genetic variation across the strains (Fig. 2).  210 
The 84 isolates were also tested for catalase activity, diacetyl production and the final pH of fermented 211 
RSM during pre-screening (Table 3). A single representative for each biotype (based on fingerprint and 212 
similarities in the pre-screening characteristics: catalase negative isolates that were capable of producing 213 
diacetyl were considered desirable) was used in subsequent analyses. A pH < 4.7 after 24 h of 214 
fermentation is also desirable, as it may be indicative of lactic acid production. The pH of control RSM 215 
was 6.50  0.03. Eight isolates from CCH demonstrated higher proteolytic activity (DH% > 8.9%) than 216 
Lb. helveticus DSM1313, used here as a reference commercial strain with high proteolytic activity 217 
(Table 3).  In addition, s6-HTCH with a pH > 6.0 but with the highest DH% (>17.88) was also selected.   218 
The peptide profiles by RP-HPLC from s10-AVCH and s12-AVCH displayed more diverse and 219 
abundant peaks (Fig. 3B and 3C), similar to the chromatogram of AVCH (Fig. 1B). The remaining six 220 
strains which elicited higher DH% than DSM13137 were isolated from HTCH. Whilst, s6-HTCH 221 
displayed the highest DH%, it did not show as many peaks as s10-AVCH or s12-AVCH. This could be 222 
explained by the high final pH (kept above 6.4) for this strain which allowed the caseins to remain 223 
soluble which resulted in more extensive hydrolysis as shown by the peptide profile between Rt 40 and 224 
50 min (Fig. 3A) and the production of very small peptides or FAA  that would have eluted with the 225 
solvent and/or were at concentrations below the detection limits. 226 
3.4 Bioactivity assays in fermented milk by selected hydrolytic strains 227 
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Three strains, s6-HTCH, s10-AVCH, s12-AVCH, with desirable characteristics isolated in aerobic 228 
conditions were chosen for ACEi and antioxidant activity (AO). The inhibitory efficiency ratio (IER) is 229 
the quotient of ACEi% divided by the TP concentration providing a better approach to the potency of 230 
inhibition than just reporting ACEi%.   The IER of DSM13137 increased over time and it was the 231 
highest of all the fermented milk fractions (Table 4), followed by s10 and s12 which were not 232 
significantly different (P<0.01) with IER  9. Interestingly, s6 showed the lowest activity among the 4 233 
strains despite showing higher DH%. Moreover, IER value decreased after 48 h of fermentation 234 
suggesting further breakdown of bioactive peptides by proteolysis into inactive AA.  235 
 236 
LAB may also generate antioxidant peptides during fermentation (Virtanen, Pihlanto, Akkanen, & 237 
Korhonen, 2007). In this study, the antioxidant activity of the fermented samples was evaluated by both 238 
FRAP (Fig. 4A) and the ABTS methods (Fig. 4B). Both methods showed the highest AO for 239 
DSM13137 closely followed by the three strains assessed. Also, there was an increase of AO 240 
fermentation time for all strains at 48 hours compared to 24 hours. This positive correlation of AO with 241 
degree of hydrolysis is supported by results previously reported where CCH showed higher antioxidant 242 
activity with time of ripening (Aguilar-Toalá, Vallejo-Cordoba, Hernández-Mendoza, & González-243 
Córdova, 2015).  The range of AO observed for ABTS scavenging, 50 to 87% (>1600 mol/L TEAC),  244 
is higher than that found on sweet whey (36%) and -lactoglobulin (26%)  hydrolysates obtained with 245 
protease N ‘Amano’ after 6 hours of hydrolysis (Welderufael, 2011). Nevertheless, it is known that 246 
caseins are more susceptible to proteolysis than whey proteins, resulting in an increased AO (Power, 247 
Jakeman, & Fitzgerald, 2013).  Moreover, Virtanen et al. (2007) reported AO as 860 mol/L TEAC in 248 
fermented milk by a combination LAB, including Leuconostoc cremoris, Lactococcus lactis 249 
ATCC19435 and Lb. acidophilus ATCC4356. Soleymanzadeh et al. (2016) reported antioxidant activity 250 
of Leuconostoc lactis SM10, isolated from a traditional fermented camel milk, obtaining 1484 and 251 
311.66 mol/L TEAC after 24 hours of fermentation of camel and bovine milk, respectively using the 252 
ABTS method. Interestingly, the AO reported in this study for DSM13137 (2138.95 20.23 mol/L 253 
TEAC), followed by strain s6 (2059.06  26.27 mol/L TEAC) after 48 hours of fermentation are 254 
higher than those previously reported.  Overall, the three selected isolates from CCH (s6-HTCH, s10-255 
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AVCH and s12-AVCH), as well as DSM13137, show great capability to elicit AO activity upon milk 256 
fermentation.  257 
4. CONCLUSIONS  258 
In this study we reported for the first time the proteolytic activity in Chiapas cheese (CCH), particularly 259 
from the Veracruz (AVCH) and Tabasco (HTCH) regions. There was high proteolytic activity in both 260 
cheeses, but as supported by both the free amino acids content and the peptide profile, higher proteolytic 261 
activity was found in AVCH than in HTCH.  Interestingly AVCH contained high amounts of essential 262 
amino acids as FAA and the antihypertensive GABA (0.78 g/kg); this amount is greater than what has 263 
been found in other cheese made of cow’s milk and indicates the presence of LAB with capabilities to 264 
synthesise GABA. Furthermore, the proteolytic capabilities of microbiota isolated from the CCH was 265 
also assessed and their proteolytic activity was found similar to the reference commercial strain 266 
DSM13137. Furthermore, two of the isolated strains showed similar ACE inhibitory activity to 267 
DSM13137, and all strains tested (s6-HTCH, s10-AVCH and s12-AVCH) showed very similar 268 
antioxidant activities to the reference strain and higher than those previously reported for fermented 269 
milk.  Thus, these cheese isolates with high proteolytic activity could lead to the production of 270 
functional foods with a range of biological functionalities. Further research should aim at the 271 
identification of the selected proteolytic strains and identification of major peptides responsible for the 272 
bioactivities. 273 
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Table 1. IC50 values for ACE inhibitory activity, protein content and pH for Chiapas cheese samples from 
Veracruz (AVCH) and Tabasco (HTCH) (n=2,  s.e.). 
 
Activity AVCH HTCH 
ACE inhibition (IC50 mg/mL) 2.75 ± 0.50
a 1.75 ± 0.49 a 
Total protein (g/100g) 26.95 ± 3.44 b 23.72 ± 2.88 b 
pH 3.90 ± 0.06 c 3.95 ± 0.09 c 
a,b,c No statistical difference between the means with the same letter; = 0.05. 
 
Table1
Table 2. Levels of free derivatised amino acids in raw milk and Chiapas cheese samples from Veracruz 
(AVCH) and Tabasco (HTCH). 
 
Amino acid  
Raw milk AVCH HTCH 
g/kg g/kg g/kg 
Alanine 0.005 0.283 0.072 
α-aminobutyric acid 0.001 0.022 ND 
Asparagine Tr
1
 0.135 0.009 
Aspartic acid 0.010 0.148 0.010 
γ-aminobutyric acid ND2 0.784 0.160 
Glutamic acid 0.059 0.076 0.009 
Glutamine ND 0.038 ND 
Glycine 0.008 0.095 0.020 
Histidine ND 0.003 ND 
Isoleucine 0.001 ND Tr 
Leucine 0.001 0.757 0.085 
Lysine 0.002 0.464 0.031 
Methionine Tr 0.157 ND 
Ornithine 0.001 0.179 ND 
Phenylalanine 0.001 0.223 0.032 
Proline 0.003 0.070 0.064 
Serine Tr 0.147 ND 
Threonine 0.001 0.089 ND 
Tyrosine 0.001 0.016 0.019 
Tryptophan 0.001 0.009 ND 
Valine 0.004 0.204 0.028 
 
2Tr, traces
 
1
ND, None detected. 
 
 
Table2
Table 3. Screening of lactic acid bacteria isolated from Chiapas cheeses from Veracruz (AVCH) and Tabasco 
(HTCH) for their catalase activity, diacetyl production and pH of fermented reconstituted skim milk (RSM) to 
determine those with desirable characteristics (DC).
†
 
ID Origin Atmosphere Catalase Diacetyl pH DC DH(%) 
s1 HTCH Aerobic - - 6.28  ND 
s2 HTCH Aerobic - + 5.29  8.03 
s3 HTCH Aerobic - - 5.50  ND 
s4 HTCH Aerobic - - 6.10  ND 
s5 HTCH Aerobic + + 5.71  11.11 
s6 HTCH Aerobic - + 6.46 * 17.88 
s7 AVCH Aerobic + - 6.65  ND 
s8 AVCH Aerobic + - 6.66  ND 
s9 AVCH Aerobic - - 6.58  ND 
s10 AVCH Aerobic - + 5.31 * 13.41 
s11 AVCH Aerobic + - 6.59  ND 
s12 AVCH Aerobic - + 5.54 * 11.00 
s13 AVCH Aerobic + - 6.70  ND 
s15 AVCH Aerobic - - 6.30  ND 
s16 AVCH Aerobic - - 6.74  ND 
s17 AVCH Aerobic - - 6.73  ND 
s18 AVCH Aerobic - - 6.65  ND 
s19 HTCH Aerobic - - 5.98  ND 
s21 HTCH Aerobic + - 6.77  ND 
s22 HTCH Aerobic - - 6.23  ND 
s23 HTCH Aerobic - - 6.09  ND 
s24 HTCH Aerobic - - 6.18  ND 
s25 HTCH Aerobic - - 6.10  ND 
s26 HTCH Aerobic - - 5.88  ND 
s27 HTCH Aerobic + + 5.49  8.78 
s28 HTCH Aerobic - + 4.63 * 11.26 
s30 HTCH Anaerobic   6.24  ND 
Table3
s31 HTCH Anaerobic - + 5.28  0.00 
s32 HTCH Anaerobic - + 6.62  1.79 
s33 HTCH Anaerobic - + 5.11  1.16 
s34 HTCH Anaerobic - - 5.71  ND 
s35 HTCH Anaerobic - + 4.80  4.01 
s36 HTCH Anaerobic - + 4.92  3.10 
s37 HTCH Anaerobic - - 6.11  ND 
s38 HTCH Anaerobic - - 6.08  ND 
s39 HTCH Anaerobic - + 5.98  5.43 
s40 HTCH Anaerobic - + 5.60  4.00 
s41 HTCH Anaerobic - - 5.94  ND 
s42 HTCH Anaerobic - - 6.44  ND 
s43 HTCH Anaerobic - + 4.70 * 10.24 
s44 HTCH Anaerobic - + 4.48  8.32 
s46 HTCH Anaerobic - + 4.83 * 10.62 
s47 HTCH Anaerobic - - 6.64  ND 
s48 HTCH Anaerobic - + 4.98 * 10.43 
s49 HTCH Anaerobic - - 4.06  ND 
s50 HTCH Anaerobic - + 5.38  4.88 
s51 HTCH Anaerobic - + 5.27  3.63 
s52 HTCH Anaerobic - - 4.21  ND 
s53 HTCH Anaerobic - - 4.50  ND 
s54 HTCH Anaerobic - - 6.60  ND 
s55 AVCH Anaerobic - - 5.92  ND 
s58 AVCH Anaerobic - - 6.10  ND 
s59 AVCH Anaerobic - - 6.80  ND 
s60 AVCH Anaerobic - - 6.60  ND 
s61 AVCH Anaerobic - - 6.80  ND 
s62 AVCH Anaerobic - - 6.81  ND 
s63 AVCH Anaerobic - - 6.73  ND 
s65 AVCH Anaerobic - - 6.81  ND 
s66 AVCH Anaerobic - - 6.26  ND 
s67 AVCH Anaerobic - - 6.93  ND 
s68 AVCH Anaerobic - - 6.60  ND 
s69 AVCH Anaerobic - - 6.13  ND 
s70 AVCH Anaerobic - - 5.91  ND 
s71 AVCH Anaerobic - + 6.16  5.67 
s72 AVCH Anaerobic - - 6.36  ND 
s73 AVCH Anaerobic - - 6.69  ND 
s74 AVCH Anaerobic - - 6.64  ND 
s76 AVCH Anaerobic - + 5.37  0.0 
s86 AVCH Anaerobic - - 6.14  ND 
†
 (-) negative reaction; (+) positive reaction. pH of uninoculated RSM (control) was 6.500.03. Those strains showing an 
equivalent fingerprint have been omitted. DH(%), degree of hydrolysis of milk proteins (%); negative control (RSM) 3.18% 
and positive control (Lactobacillus helveticus DSM1317) 8.84%. The specific desirable characteristics were catalase 
negative, capable of diacetyl production and DH% > 8.9%. 
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Table 4. Inhibitory efficiency ratio (ACEi%/[total protein mg mL
-1
]) of fermented milk whey samples of selected 2 
strains (s6-HTCH, s10-AVCH & s12-AVCH) compared to Lb. helveticus DSM13137. Results are represented by the 3 
mean  SD (n=2). 4 
 5 
Time (hours) DSM13137 s6-HTCH s10-AVCH s12-AVCH 
24 12.32  0.01a,b 4.61  0.49 b,c 9.75  0.31b,c 9.09  0.01 b 
48 15.42  0.25a,b 3.74  1.21b,c 8.32  1.31 b,c 9.11  0.59 b,c 
* Treatments with the same letter are not significantly different, Tukey HSD test: =0.05 6 
 7 
 8 
 9 
 10 
Table4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. RP-HPLC peptide profiles of A) reconstitute skimmed milk (RSM); B) Chiapas cheese from Veracruz 
(AVCH); and C) from Tabasco (HTCH). 
 
0.0 12.5 25.0 37.5 50.0 62.5 75.0 90.0
-100
0
100
200
300
mAU
min
WVL:214 nmAVCH
0.0 12.5 25.0 37.5 50.0 62.5 75.0 90.0
-100
0
100
200
300
mAU
min
WVL:214 nmHTCH
A) 
B) 
C) 
Figure1
  
Fig. 2. Investigation of the genetic variation of lactic acid bacteria isolated from Chiapas cheeses using RAPD-PCR (OPA-09). 
Profiles are labelled with gel number followed by isolate number (e.g. Gel1_33, refers to isolate 33 whose RAPD-PCR product 
was run in Gel 1). Grey shading highlights potential replicates of the same strain (100% similarity between RAPD-PCR profiles). 
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Fig. 3. Reverse phase chromatograms of peptide profiles of fermented milk whey fractions of lactic acid 
bacteria (s6-HTCH, s10-AVCH, s12-AVCH, s28-HTCH, s43-HTCH, s46-HTCH, and s48-HTCH) isolated 
from Chiapas cheese samples.  
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Fig. 4. Antioxidant activity of fermented milk whey fractions after 24 (dark grey) and 48 hours (light grey) 
fermentation by Lactobacillus helveticus DSM13137, s6-HTCH, s10-AVCH, and s12-AVCH. A) FRAP; and 
B) ABTS. Data are presented as means  SD (n=3). Treatments with the same letter are not significantly 
different, Tukey HSD test: =0.05 
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